| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acae886d7fc13db991247cb273eb71bd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4728 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01J49-0036 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2011-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad22d3faee47e6216a53b9ce262cc046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_572494bcd35c1191a85e1c064db2703a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d5b91e9c36671c766c6c09fee8ec6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec1c397deefabc33a29baf040c5b9d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6447d78053b2e275e03af892f93ce446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b11179c61a0ac89e12a934704d89896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb64bb0e2a8c42033b9917032458bae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60e7eab7cd90a4727dc94526425c28ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3787ef4d5fb01a356eaeb96f9198a34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320b2fe654fcdfb8a3f04019eaa81dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddbe17c218a498d467fadab1f735b8be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1601a6e26b0e51f23f6267b12d1db6b3 |
| publicationDate |
2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3101426-A2 |
| titleOfInvention |
Alpha2-macroglobulin from cerebrospinal fluid as an index marker for neuromyelitis optica |
| abstract |
The purpose of the present invention is to develop: a method for selectively separating a glycoprotein derived from the central nervous system from a body fluid or a central nervous system cell; and a method for searching for an index marker for central nervous system diseases, which utilizes the aforementioned method. A protein derived from the central nervous system, which occurs in a trace amount in a body fluid or a central nervous system cell, can be selectively enriched by a two-stage separation procedure comprising removing a glycoprotein having sialic acid at a non-reducing terminal thereof from the body fluid or the central nervous system cell and then separating a glycoprotein having N-acetylglucosamine at a non-reducing terminal thereof. |
| priorityDate |
2010-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |